Diagnosis of cervical carcinoma: Report of a case.

Cervical carcinoma is the most common among carcinomas, and numerous cases of late stage of cervical carcinoma are still found. The Ministry of Public Health has realized this problem and is carrying on a mass screening program for early detection of cervical cancer over the entire country. Everybody should participate regularly in order that this program is successful in the near future. The unmarried women were after 20 years of age. Then screening technique should be VCE technique. Married women should be checked after marriage and unmarried after 20 years of age. Then women should be checked every 6 months except during menstruation or in cases of notified. A case of late of cervical cancer was reported. This patient was a good example for many aspects of complications and results of late cancer. After retroperitoneal mass was found the first day attending the O.P.D. at Siriraj Hospital but an appointment in 6 weeks time was made rather than having immediate examined and treatment. The tumor progressed rapidly and the case became more complicated. The patient was investigated and treated completely during this late stage but could not be helped. Many factors such as time and expenses were lost. For these reasons prevention before late of cancer through early detection should be conducted.

Update results of intrabifurcations of aorta infusion by high dosage mitomycin-C in uterine cervical squamous cell carcinoma stage II, III (Report of 35 cases).

Thirty-five new patients with squamous cell carcinoma of the cervix stage II and III, with refusal of radiation therapy were treated with a single dose of mitomycin-C 35 mg/m2 intrabifurcation of the aorta infusion. 85.7 percent had clinically complete regression and 5.71 percent had partial regression. Twenty-seven cases of the clinically complete regression were treated by radical hysterectomy and pelvic nodes dissection. There were 10 cases (37.03%) showing pathologically complete regression, 11 cases (40.74%) showing small residual cancer in the cervix and 6 cases (22.22%) showing residual cancer in the cervix and pelvic nodes. The follow up performed after 18-30 months, revealed recurrence or metastases in 18.51 percent of the cases. Mild nausea, alopecia, weakness, anorexia, moderately depressed in the second week after treatment.